Polydopamine Nanostructures as Biomaterials for Medical Applications.

Polydopamine is a versatile and organic material that can be deposited as a conformal film with nanometer thickness on virtually any substrate. Much of the initial foundational work regarding polydopamine synthesis and processing was reported during the 2000s. Latter years have witnessed increasing interest and widespread adoption of polydopamine as a material for many applications including medicine.

Texture-Dependent Adhesion in Polydopamine Nanomembranes.

The conformal nature of in situ polymerization of adhesive dopamine molecules permits the strong underwater adhesion between polydopamine (PDA) nanomembranes and the target substrates. However, the adhesive interaction between the postdeposit PDA nanomembranes and other macrobodies is strongly influenced by the texture of PDA nanomembranes. Here we report the texture-dependent adhesion of PDA nanomembranes both in air and aqueous environments.

In vitro electrochemical characterization of polydopamine melanin as a tissue stimulating electrode material.

The properties of redox active polydopamine melanin (PDM) films as a coating material for neural electrodes were evaluated. PDM films with nanometer-scale thicknesses exhibit dc bias dependent charge injection capacities (CIC) with maximum values of 110 ± 23 µC cm at 0.2V (vs Ag/AgCl) and reduce the interfacial impedance compared to inorganic conducting films.

Laparoscopic liver resection for malignant liver tumors, why not more?

Purpose: The precise role of laparoscopic liver resection in liver malignancies remains controversial despite an increasing number of publications that have used the laparoscopic resection of benign liver tumors. This study was performed to assess the feasibility, safety, and outcome of laparoscopic liver resection for malignant liver tumors.

Methods: This study is a retrospective review of the profiles, pathology, surgery and outcome performed on 61 patients who had undergone laparoscopic liver resection for liver malignancies between January 2004 and March 2011.